Aspire Biopharma Holdings, Inc. Share Price
ASBPAspire Biopharma Holdings, Inc. Stock Performance
Open $0.51 | Prev. Close $0.54 | Circuit Range N/A |
Day Range $0.29 - $0.56 | Year Range $0.05 - $2.41 | Volume 1,70,302 |
Average Traded $0.46 |
Aspire Biopharma Holdings, Inc. Share Price Chart
About Aspire Biopharma Holdings, Inc.
Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States. It offers Instaprin, a sublingual aspirin product that is a soluble, PH neutral, and fast acting aspirin, which addresses cardiology emergencies and pain management. The company is also developing formulations for sublingually administered products, including a melatonin sleep-aid product; vitamins D, E, and K; testosterone; and semaglutide product. In addition, it is developing formulations for anti-nausea products, anti-psychotic products, ED drugs, seizure medication, and other classes of drugs through sublingual administration; and caffeine products, such as a formula for a single dose sublingual pre-workout supplement. The company was founded in 2021 and is headquartered in Estero, Florida.
Aspire Biopharma Holdings, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
16-Apr-26 | $0.51 | $0.30 | +0.00% |
16-Apr-26 | $0.51 | $0.30 | -44.61% |
15-Apr-26 | $0.90 | $0.54 | -53.82% |
14-Apr-26 | $1.16 | $1.17 | +2.19% |
13-Apr-26 | $1.14 | $1.14 | +10.68% |
10-Apr-26 | $1.03 | $1.03 | -14.17% |
09-Apr-26 | $1.20 | $1.20 | +1.69% |